Third Rock Ventures II, L.P. Insider Trading $JNCE Jounce Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Third Rock Ventures II, L.P..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and 10% Owner in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and 10% Owner in Revolution Medicines, Inc. ($RVMD).

Over the past year Third Rock Ventures II, L.P. has been an insider in 2 companies. The total value of shares held by Third Rock Ventures II, L.P. in these companies amounts to $76,947,442.

Third Rock Ventures II, L.P. 10% Owner
Allena Pharmaceuticals, Inc.
10% Owner
Blueprint Medicines Corp
10% Owner
Global Blood Therapeutics, Inc.
10% Owner
Jounce Therapeutics, Inc.
10% Owner
MyoKardia, Inc.
10% Owner
Revolution Medicines, Inc.
10% Owner
Sage Therapeutics, Inc.
$ 76947442 The total value of shares held by Third Rock Ventures II, L.P.
Insider Rank

Third Rock Ventures II, L.P. ranks 366 out of 350,000 insiders. Go to Insider Ranking to see more.

Third Rock Ventures II, L.P. in Jounce Therapeutics, Inc.

Trading Symbol: JNCE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 4,447,829 shares
Current Value: $76,947,442
Latest Transaction: Jun 14 2021
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 2x
Sell: 4x
Shares Bought: 12,737,124
Shares Sold: 3,765,000
Share Difference: +8,972,124
Value Difference: +$108,773

Latest Insider Trading Transactions of Third Rock Ventures II, L.P. in Jounce Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000024
Value of Sales ($)000000108,773

Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 14 2021JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,500,00004,447,8295.9 M to 4.4 M (-25.22 %)
Mar 15 2021JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,250,00006,500,3497.8 M to 6.5 M (-16.13 %)
Nov 19 2020JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellS7.2515,000108,7739,215,3499.2 M to 9.2 M (-0.16 %)
Nov 13 2020JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00009,230,34910.2 M to 9.2 M (-9.77 %)
Feb 03 2017JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0011,250,00000
Feb 03 2017JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0035,750,00000
Feb 03 2017JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerBuyC0.003,048,78003,048,7800 to 3 M
Feb 03 2017JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerBuyC0.009,688,344010,230,349542 K to 10.2 M (+1,787.50 %)

Page:   1